Market Overview

Bayer CropScience To Acquire AgraQuest

Related BAYRY
Bayer CEO Weighs In On Guidance, Listing Of Material Science Business And Syngenta
Recon Capital CIO Kevin Kelly On Investing In German Blue Chip Equities
Foamix Pharma up 8% on FDA clearance of Bayer's Finacea for inflammatory skin disease (Seeking Alpha)

Bayer (OTC: BAYRY) reported that its pesticides arm CropScience will buy US-based biological company AgraQuest for $425 million plus milestone payments.

AgraQuest's revenue came in at $40 million last year.

Bayer shares gained 1.65% to close at $73.41 on Tuesday.

Posted-In: merger and acquisitionNews M&A


Related Articles (BAYRY)

Get Benzinga's Newsletters